Unlike prescription GLP-1 drugs such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), these supplements lack rigorous clinical evidence and regulatory oversight
It is very common and not a result of weakness or poor control
So, similar to the hormone, these drugs tell the pancreas to release more insulin when blood sugar rises (typically during and after eating)
When the compounds, found naturally in products such as red meat and milk, were used together the researchers found that the concentration of free radicals in mitochondria, energy-producing organelles in their cells, were lower than when used independently or not at all
Future Outlook: Innovations in Obesity and Diabetes Treatments The future of obesity and diabetes care will likely include: Combination therapies (GLP-1 + amylin analogs)
Herein, we successfully switched a patient with acromegaly from a DPP-4 inhibitor to a GLP-1 analog due to pasireotide-induced deterioration of glycemic control